[1] SUN-HEE KIM. Novel compound 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) prevents 2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor.[J]. Molecular Pharmacology, 2006, 69 6: 1871-1878. DOI:
10.1124/mol.105.021832[2] MARC VELDHOEN. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells.[J]. ACS Chemical Health & Safety, 2009: 43-49. DOI:
10.1084/jem.20081438[3] STEPHEN M. CARLIN John J M David D Ma. T-cell potential of human adult and cord blood hemopoietic stem cells expanded with the use of aryl hydrocarbon receptor antagonists[J]. Cytotherapy, 2013, 15 2: Pages 224-230. DOI:
10.1016/j.jcyt.2012.10.014[4] TEJAS S LAHOTI. Aryl hydrocarbon receptor antagonism mitigates cytokine-mediated inflammatory signalling in primary human fibroblast-like synoviocytes.[J]. Annals of the Rheumatic Diseases, 2013, 72 10: 1708-1716. DOI:
10.1136/annrheumdis-2012-202639[5] BRIAN K. PETROFF . The aryl hydrocarbon receptor agonist 2,3,7,8-tetrachloro-dibenzo-p-dioxin (TCDD) alters early embryonic development in a rat IVF exposure model[J]. Reproductive toxicology, 2011, 32 3: Pages 286-292. DOI:
10.1016/j.reprotox.2011.07.005